Skip to main content
. 2018 Nov;10(11):6077–6087. doi: 10.21037/jtd.2018.10.02

Table 1. Baseline characteristics of patients with TB pleurisy.

Variables Total (N=367) GPS 0 (n=119) GPS 1 (n=198) GPS 2 (n=50) P value
Age (year) 49.5±21.5 46.0±19.4 48.9±21.3 60.1±23.9 <0.001
Males 209 (56.9) 65 (54.6) 118 (59.6) 26 (52.0) 0.515
BMI 21.6±3.3 21.9±2.8 21.5±3.7 20.8±3.2 0.158
Smoking
   Current smoker 78 (21.3) 20 (16.8) 49 (24.7) 9 (18.0) 0.205
   Ex-smoker 45 (12.3) 11 (9.2) 31 (15.7) 3 (6.0) 0.084
PYs 23.9±20.4 20.6±17.2 24.6±21.7 28.2±20.2 0.509
Underlying disease
   DM 29 (7.9) 4 (3.4) 18 (9.1) 7 (14.0) 0.043
   COPD 4 (1.1) 2 (1.7) 2 (1.0) 0 (0.0) 0.623
   Other malignancy 11 (3.0) 3 (2.5) 7 (3.5) 1 (2.0) 0.794
   LC 4 (1.1) 1 (0.8) 3 (1.5) 0 (0.0) 0.621
   Autoimmune disease 4 (1.1) 1 (0.8) 3 (1.5) 0 (0.0) 0.621
   Post-transplantation 1 (0.3) 1 (0.8) 0 (0.0) 0 (0.0) 0.352
   ESRD 3 (0.8) 1 (0.8) 2 (1.0) 0 (0.0) 0.777
History of TB 50 (13.6) 12 (10.1) 28 (14.1) 10 (20.0) 0.219
Symptoms
   Dyspnea 142 (38.7) 38 (31.9) 84 (42.4) 20 (40.0) 0.175
   Chest pain 176 (48.0) 61 (51.3) 95 (48.0) 20 (40.0) 0.409
   Cough 73 (19.9) 28 (23.5) 31 (15.7) 14 (28.0) 0.071
   Fever 48 (13.1) 12 (10.1) 27 (13.6) 9 (18.0) 0.357
   General weakness 7 (1.9) 2 (1.7) 5 (2.5) 0 (0.0) 0.494
   Weight loss 11 (3.0) 4 (3.4) 5 (2.5) 2 (4.0) 0.827
   Hemoptysis 4 (1.1) 3 (2.5) 1 (0.5) 0 (0.0) 0.179
Effusion site 0.427
   Right 225 (61.3) 76 (63.9) 118 (59.6) 31 (62.0)
   Left 135 (36.8) 43 (36.1) 74 (37.4) 18 (36.0)
   Bilateral 7 (1.9) 0 (0.0) 6 (3.0) 1 (2.0)
Accompanied PTB 141 (38.4) 43 (36.1) 81 (40.9) 17 (34) 0.505

Data are presented as n (%) or mean ± SD. GPS, Glasgow Prognostic Score; BMI, body mass index; PYs, pack years; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; LC, liver cirrhosis; ESRD, end stage renal disease; TB, tuberculosis; PTB, pulmonary tuberculosis.